Table 1 |
|
Outcome measures collected at baseline |
|
• Demographical details (first name, age, sex, E-mail, first part of post code) |
|
• Condition being treated |
|
• Previous treatment with biologic agents |
|
• Current medications including methotrexate |
|
• Functional status and general quality of life |
|
- CGI-S |
|
- EQ-5D and EQ VAS |
|
• Disease-specific quality of life |
|
- HAQ for patients with rheumatoid arthritis |
|
- CHAQ for patients with juvenile idiopathic arthritis (JIA) |
|
- DSLI for patients with psoriasis |
|
• DAS-28 for patients with rheumatoid arthritis |
|
|
|
CGI-S Clinical Global Impression - Severity of Illness, CHAQ Child Health Assessment Questionnaire, DAS-28 Disease Activity Score-28, DSLI Dermatology Life Quality Index, EQ-5D EuroQol 5 dimensions, EQ VAS, EuroQol visual analogue scale, HAQ Health Assessment Questionnaire |
|
Wade et al. BMC Medical Research Methodology 2011 11:91 doi:10.1186/1471-2288-11-91 |